Genprex Inc (GNPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.56M
Last updated: Nov 17, 2026 at 4:39 PM ET
Genprex Inc (GNPX) Stock Chart
Genprex (GNPX) has a latest price of $1.90 on Nov 17, 2026, 97.8% below its 52-week high of $85.14. Its price fell 97.9% over the past 12 months. The month-end price fell 100.0% since Mar 2018, a compound annual decline of 73.6%.
Price Chart
From Mar 2018 to Oct 2026, its highest month-end close was $680,879.12 in Apr 2018 and its lowest $2.24 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GNPX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GNPX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 51.9%, and over 6 months it fell 89.3%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 93.9%.
| Period | Change |
|---|---|
| 1 month | -10.0% |
| 3 months | -51.9% |
| 6 months | -89.3% |
| 12 months | -97.9% |
| 12 months, with dividends | -97.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -100.0% | -93.9% |
| 5 years | -100.0% | -88.3% |
| Since Mar 2018 | -100.0% | -73.6% |
Price by Year
Its best calendar year was 2020, when the price rose 1,196.9%, and its weakest was 2025, when it fell 95.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.24 | -94.2% |
| 2025 | $38.46 | -95.9% |
| 2024 | $935.82 | -90.7% |
| 2023 | $10,109.89 | -84.1% |
| 2022 | $63,736.26 | +10.7% |
| 2021 | $57,582.42 | -68.4% |
| 2020 | $182,417.58 | +1,196.9% |
| 2019 | $14,065.93 | -70.9% |
Trading Range
The price is 27.5% below its 50-day average of $2.62 and 89.0% below its 200-day average of $17.26.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.90 | |
| 52-week high | $85.14 | -97.8% |
| 52-week low | $1.71 | +11.1% |
| 50-day average | $2.62 | -27.5% |
| 200-day average | $17.26 | -89.0% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.76 |
| Largest fall, 1 year | -98.1% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GNPX
What is GNPX's 1-year price change?
Genprex's price fell 97.9% over the past 12 months. With dividends included, the 12-month total return was -97.9%.
What is GNPX's 5-year price change?
Genprex's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 88.3%. These figures leave out dividends.
What is GNPX's 52-week high and low?
Genprex's 52-week high is $85.14 and its 52-week low is $1.71. Its latest price of $1.90 on Nov 17, 2026 is 97.8% below the high.
What is GNPX's beta?
Genprex's 1-year beta against the S&P 500 is 0.76, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 98.1%.
Is the GNPX chart free?
Yes. Advanced Charting for GNPX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GNPX pages: Overview, Charting, Earnings, Financials, Statistics, Competitors